8-KThe WireRoutine
Shareholder Vote
Filed Jun 24, 2024 · 2y ago · Accession 0001193125-24-166938
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- AN2 Therapeutics, Inc.
- Ticker
- ANTX
- CIK
- 1880438
- Form type
- 8-K
- Filing date
- Jun 24, 2024
- Report date
- Jun 19, 2024
- Document
- d860451d8k.htm
- Size
- 195 KB